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Abstract
4-hydroxyphenylglycine (hpg) is a small non-proteinogenic amino 
acid, present in secondary metabolites such as teicoplanin, ram-
oplanin or enduracidin. Due to its physico-chemical properties, 
hpg occupies a crucial role in the determination of compound 
structures, thereby establishing therapeutically relevant proper-
ties. Compounds containing hpg are predominantly synthetized 
by modular Nonribosomal peptide synthetases (NRPS), contain-
ing adenylation domain bearing modules, which can specifically 
integrate hpg into a growing peptide. NRPS may require the spe-
cific binding of an integral helper protein group, the MbtH ho-
mologues. Using pFAM software as a basis for the identification 
of potential hpg activating adenylation domains, 12 modules and 
their MbtH helper proteins in a total of 17 domain setups, were 
selected, expressed in E. coli and characterized in vitro including 
their MbtH homologs, and subsequently subjected to expression 
and substrate specificity characterization experiments. Heterolo-
gous expression in E. coli was observed with 9 targets, and with 
all 17, when co- expressed with MbtH or upon introduction of an 
N-terminal maltose binding protein (MBP) tag, respectively. Pyro-
phosphate exchange assays revealed, that all domains exhibited 
activity towards L- or D-4-hpg and underlined the essential role of 
MbtH homologues in the activation of hpg activating domains. In 
addition, comparing the adenylation velocities, we demonstrated 
the crucial role of NRPS starter modules, which showed an up 
to 5-fold increased activity when compared to any elongation 
module in this study. Overall, we demonstrate here a medium 
throughput system, allowing for the identification and character-
ization of specific NRPS modules. In the context of future com-
pound and NRPS engineering efforts, this may serve as a funda-
ment for the selection of domains and modules with promising 




























































Multi-modular enzymes represent a highly evolved and complex family of 
large, polycatalytic, biochemical machineries. One of the most versatile rep-
resentatives of this superfamily are the nonribosomal peptide synthetases 
(NRPS). The production of antibiotics, immunosuppressants, cytostatics, but 
also pigments can all be attributed to NRPS. Members of this group of modu-
lar enzymes can consist of up to 15 [1] functionally distinct parts or modules. 
Modules are characterized by their distinct functions in recognition, activa-
tion and condensation of a dedicated compound into a growing nonribosomal 
peptide (NRP). In order to allow for all the aforementioned functions, a mod-
ule contains a set of functionally distinct parts, or domains, each carrying 
out a distinct catalytic sub-step. Thus, a minimal module must contain an 
adenylation (A), thiolation (T) and condensation (C) domain. The adenylation 
domain, consisting of a Acore and Asub part [2] is responsible for the recogni-
tion, adenylation and thioesterification of a substrate. Through the hydrolysis 
of ATP, an AMP-substrate conjugate is formed, which is subsequently trans-
ferred to the free thiol group of the 4‘-phosphopantetheinyl- moiety (ppant), 
which is anchored to the downstream T domain [3–4]. This thioesterification 
is guided by a structural rearrangement of the Asub domain, which itself un-
dergoes a rotation by about 140° [5–6] relative to the Acore domain. The ppant 
arm, linked to the activated substrate, is itself covalently attached to a highly 
conserved serine residue which is part of the GGXS motif of the T domain 
[7–8]. To finalize peptide bond formation, the activated T-ppant-substrate 
moiety associates with the C domain where the peptide bond formation is 
guided. Upon a nucleophilic attack, a dipeptide is created which remains 
attached to the downstream ppant arm [9]. An exception to those minimal 
conditions are standalone modules and initiation or N- terminal modules of 
multi modular NRPS enzymes. These NRPS modules lack C domains due to 
the absence of an upstream module. A series of additional domains might be 
present in NRPS enzymes, but none of them is essential for the peptide chain 
formation except for the C-terminal thio esterase (Te) domain, which is crucial 
for product release. In the absence of such a domain, standalone thioesterase 
enzymes may fulfill this function.
Multiple highly selective domains for epimerization (E), halogenation, oxi-
dation and a multitude of pluripotent C domains have been identified [10–12]. 
Despite the abundance of many functionally distinct domains, some reac-
tions still require direct or indirect involvement of other factors. These may 
involve essential steps, such as the attachment of the phosphopantheteinyl 








out by a phosphopantheteinyl-transferase (sfp) [13]. An example of poten-
tially essential chaperones is the highly conserved MbtH protein [14–15]. The 
precise role of these relatively small proteins, i.e., ~70 amino acids, has re-
mained elusive. However, MbtH proteins have been shown to increase the 
adenylation activity [16] as well as the levels of NRPS expression [17]. More-
over, high affinity association with A domains seems to play a crucial role in 
the MbtH activity [18–19]. MbtH homologs are essential for some bacterial 
NRPS enzymes, but seem entirely absent from eukaryotic organisms such 
as fungi. Also, the number of MbtH copies and variants varies strongly, even 
among strains from the same organism [20] while the impact on functionality 
is very diverse. It ranges from a complete loss of functionality [21] to insignif-
icant variations in product levels [15] as gene deletion studies suggest [22]. 
Even the replacement of standalone MbtH proteins with a covalently linked, 
MbtH-like domain has been demonstrated, using RubC [23]. Recently, the 
first A domain-MbtH structure has become available, suggesting a set of con-
served residues which are tightly involved in the MbtH-NRPS association [19].
Many different NRPS products, enzymes, domains and catalytical func-
tions have been identified and assigned. A domains have long been consid-
ered to be a bottleneck in NRPS systems, fulfilling an essential gatekeeper 
function. Therefore, they were in the focus of characterization, prediction 
and engineering attempts for an extended period of time [24–26]. This has 
lead to the identification of important motifs for adenylation [27], substrate 
specificity, as well as a better understanding of the domain arrangement 
through structural analysis [2]. Despite this knowledge and use of an ever 
increasing reservoir of structures and predictive software, successful site 
directed engineering efforts are still exceptional [25;28–30]. Experiments 
targeting the elucidation of catalytic sub steps support the importance of 
A domains, though also novel targets in substrate specificity emerged, espe-
cially C domain characterization. T domains, the smallest and catalytically in-
active domain, rely mostly on a core GGXS motif resolving around the highly 
conserved serine residue, necessary for sfp dependent ppant attachment [7]. 
Due to their very high degree of structural conservation and the availability 
of crystal structures, the overall structure is well understood. Not only sin-
gle domains were structurally characterized, but also multi-domain struc-
tures as well as whole modules [31–33]. More recent studies attribute an 
engineering potential to T domains, since it has been shown that synthetic 
T domains can improve product output in vivo and in vitro [34]. Nevertheless, 
conformational changes of the NRPS enzymes during their catalytic cycle 
are not well understood. Thus, the potential for accurate predictions in the 


























































Despite many studies, C domains remain the most elusive. Early experi-
ments indicate that NRPS enzymes, including C domains, show considerable 
promiscuity in substrate incorporation [35]. However, the C domain never 
played an important role in engineering attempts. A turnaround in C domain 
perception was marked with the discovery of the essential HHxxDG motif [36] 
involved in peptide bond formation. Further experiments revealed additional 
conserved sequences related to stereochemical selection [37], indicating 
important potential bottlenecks for engineering. In terms of sequence con-
servation and domain size, C domains are exceptionally diverse [38] and are 
linked to multifunctionality [10]. This has been underlined, as condensation- 
epimerization [10] domains were discovered. Recently, more novel functions, 
most notably oxygenase recruitment, has been described [12]. In biochemi-
cal studies, NRPS catalytic sub steps have been investigated and likely bot-
tlenecks were identified [39]. However, crucial information about overruling 
complexities remain widely unknown as no complete NRPS crystal structure 
is available. Even with the high number of predictive tools and genomic data, 
a systematic analysis of domains remains to be a delicate task. Given the 
reservoir of novel amino acids that can be incorporated, the exploitation of 
A  domains for novel NRP production will remain an important challenge.
4-hydroxyphenylglycine (hpg) is a non-proteinogenic amino acid that is 
present in various NRPs. The 4-hydroxy group on the phenol ring makes 
hpg especially valuable for covalent cross- linking, side branching and cir-
cularization of large NRPs [40–41]. The inclusion of higher order structures 
can vastly improve relevant properties and spectra of bioactive substances. 
Thus, the introduction of hpg into scaffold molecules such as antibiotics, 
fungicides and other relevant compounds has the potential to create novel 
classes of pharmaceuticals, bypassing contemporary problems, such as the 
widespread antibiotic resistance. Using fundamental techniques for com-
pound [42], gene and domain determination [43–44], paired with web based 
software for substrate specificity prediction [45], a selection of putative hpg 
activating modules were identified and selected. These were produced in 
E. coli in the absence and presences of MbtH proteins, purified and assayed 
for activity and specificity. These data provide a reference for future explora-
tion of hpg units and the construction of novel chimeric NRPS enzymes that 














Selection and determination of hpg activating domains
Putative hpg activating modules were identified using the protein databases 
UniRef100, NCBI environmental as well as others as a resource. In a first step 
putative NRPS protein sequences were extracted, based on concurrent pres-
ence of Pfam [46] motifs for AMP-binding, ppant-binding, and condensation 
domains. The hypothetical NRPS domain structures were determined and 
potential adenylation domains classified as part of a starter or elongation 
module. To predict the preferred amino acid bound by these adenylation do-
main sequences, they were analyzed using the NRPSpredictor platform [47] 
which includes the identification of the “specificity conferring” code by 
Stachelhaus [27]. The NRPS modules containing adenylation domains with 
at least 70 % identity to the Stachelhaus code for putative hpg binding were 
used for final selection.
Cloning, plasmids and culture conditions
Cloning was performed using E. coli DH5α. Selecting with 50 µg/ml neomycin 
for pSCI242/243 plasmids (pBR322ori; pBAD, araC; FdT); 100 µg/ml ampicil-
lin for pMAL-c5x plasmids (pMB1ori; bla; pTac; lacIq; rrnb T2) and 15 µg/ml 
chloram phenicol for pACYCtac-MbtH plasmids (p15Aori; cat; pTac; lacIq), re-
spectively. E. coli BL21 (DE3) strain was used for expression of the adenyla-
tion domains. All cultures were grown using 2xPY (15 g/l bacto- tryptone, 
10 g/l yeast extract, 10 g/l sodium chloride, pH 7.0) at 37 °C and 200 rpm. 
Synthetic DNA fragments of domains were ordered at DNA 2.0 and codons 
optimized for expression in E. coli. Fragments were subsequently subcloned 
using the available NdeI × SbfI sites (pMAL-c5x, N8108S, New England Bio-
labs Inc., Ipswich, MA).
Expression and purification of hybrid NRPS and hpg modules
Cultures were grown to an OD600 of 0.6 in 2xPY medium, transferred to 
18 °C and 200 rpm for 1 h, and subsequently induced using 0.5 mM IPTG 
and 0.2 % L-arabinose. Harvest followed 18 hours after induction by spin-
ning at 3500 g for 15 minutes. After resuspension in lysis buffer (50 mM 


























































inhibitor (Roche, Basel, CH, REF 04693159001), cells were disrupted using 
sonication (6 s/15 s; on/off, 60 cycles, 10 µm amplitude) and cell-free lysate 
obtained by centrifugation at 4 °C, 13000 g, 15 minutes. Enzymes were pu-
rified by means of Ni-NTA bead (Qiagen, Hilden, Ger, No. 30210) supported 
his-tag affinity purification using gravity flow. Wash steps were performed 
using wash buffer (50 mM HEPES pH 7.0, 300 mM NaCl, 20 mM imidazole) 
and a one-step elution using elution buffer (50 mM HEPES pH 7.0, 300 mM 
NaCl, 250 mM imidazole). Imidazole was removed, while simultaneously 
concentrating the sample with Amicon®-50 spin filters (Amicon® Ultra 
 Ultracel — 50K, Merck Millipore, Billerica, MA, USA, UFC 805024). Protein 
concentrations were determined using BioRad DC assay kit. All fractions 
were subsequently analyzed on a 10 % SDS-PAGE. Insoluble expression was 
determined using the solubilized cell debris in 8 M UREA. Gels were stained 
using a 0.025 % coomassie stain and images taken using an imaging cabi-
net (FUJIFILM, Tokyo, Jp, LAS-4000). A domain — MbtH stoichiometry was 
quantified by means of 2-D densitometric analysis using AIDA Image Ana-
lyzer v.4.22 software.
Substrate profiling of putative hpg activating domains
The substrate profile and promiscuity of putative hpg activating domains 
was evaluated using the in vitro pyrophosphate exchange kit EnzCheck 
(EnzCheck, Thermo Fischer Scientific, Waltham, MA, USA, E6645). Iso-
lated enzyme was tested at a concentration of 1 µM in a 96-well setup and 
a total reaction volume of 100 µl. L- or D-4-phenylglycine (Pg); L- or D-4-
hydroxyphenyl glycine (hpg) and L-phenylalanine, serving as negative control, 
were tested respectively. All substrates were screened at a concentration of 
0.1 and 1 mM. The absorption at 360 nm of the coupled indicator substrate 
MESG (2-amino-6-mercapto-7-methylpurine ribonucleoside) was measured 
in 5 minutes intervals over a period of 4 h. Activity was compared as a func-
tion of (PPi) µM min-1 (enzyme) µM-1.
Results
Selection and determination of putative hpg activating domains
Putative hpg activating domains were identified using various databases. 
































































































































































































































































adenylation domain sequences were subsequently analyzed using the NRP-
Spredictor platform [47]. Hpg affinity was finally evaluated using NRPSpre-
dictor data, leading to a list of 58 potential candidate modules. Sequences of 
43 modules had at least 80 % identity with the predicted  Stachelhaus [27] 
hpg core motif (Supplementary figure 1). Upon further analysis of the puta-
tive targets, 43 modules could be subdivided into 7 initiation and 36 elon-
gation modules. Additionally, we elucidated that those domains can be as-
signed to 28 multi-modular NRPS, arranged in 14 secondary metabolite gene 
clusters. 13 out of 14 can be assigned to a bacterial host, though the origin of 
two remains elusive, as they were obtained from metagenomic data.
After consideration of the adenylation domain placement within the mod-
ule as well as the availability and feasibility of source material, 12 module 
adenylation domains were selected (Figure 1). The adenylation domains were 
subsequently ordered in different setups, either as single A domain or in-
cluding their adjacent T, Te or C domains. All genes were codon optimized 
for E. coli by the manufacturer (DNA 2.0). This lead to a total of 18 constructs 
as indicated in Table 1. In addition to the NRPS, their putative corresponding 
MbtH homologs were identified. MbtH proteins have a chaperoning function, 
which is potentially essential for adenylation activity and expression. Iden-
tification followed taking the conserved MbtH core motif [17], leading to a 
Table 1 — Final selection of target domain constructs.
Construct Organism NRPS setup Initiation Reference
Tcp9 Actinoplanes teichomyceticus ATCC53649 AT CATE Y [51]
Hpg1 Streptomyces toyocaensis NRRL 15009 AT CATE Y [52] 
Hpg3/4 Nonomuraea sp. ATCC 39727 AT CATE Y [53] 
Hpg11/12 Amycolatopsis mediterranei CATE CAT N [54] 
Hpg13/14 Amycolatopsis mediterranei CATE CAT N [54] 
Hpg19 Streptomyces coelicolor A3(2) CAT CATE CAT CATE N [55]
Hpg20/26 Streptomyces lavendulae CATE N [56] 
Hpg21 Streptomyces toyocaensis NRRL 15009 CATE CAT N [52] 
Hpg22 Actinoplanes teichomyceticus ATCC53649 CATE CAT N [51]
Hpg23 uncultured CATE CAT N [57]
Hpg24 Amycolatopsis orientalis CATE CAT N [58]
Hpg25/27 uncultured CATE CAT N [57]
Construct code, domain setup of target NRPS and corresponding module are indicated. Fur-
thermore module placement, Initiation or other is shown. Constructs derived from the same 






selection of 7 MbtH homologs associated with dedicated NRPS gene clusters. 
Their corresponding sequences were furthermore analyzed for hypothetical 
NRPS binding motifs (Figure 2A/B). 
Heterologous expression profiling
In order to determine the expression properties of the selected putative hpg 
activating domains, they were subjected to small-scale expression experi-
ments. Constructs in the pSCI242 vector were expressed without the addi-
tion of MbtH proteins. Subsequently, the soluble fraction as well as the cell 
debris or insoluble fraction were analyzed. 9 out of 17 constructs showed 
soluble expression of their respective domain(s). However, the expression 
levels varied strongly. Hpg14, 16 and 20 showed very low amounts hardly 
traceable using coomassie staining but with the occurrence of insoluble pro-
tein (data not shown). One variant, Hpg18, allowed for the detection of insol-
uble expression only. The remaining 6 Hpg variants (Hpg11, 12, 21, 22, 23, 24) 
did not result in any heterologously-expressed protein. 
In order to improve soluble protein expression, a maltose binding protein 
(MBP) was fused to the N-terminus of the constructs. Expression trials were 
repeated, using the MBP-Hpg A domain constructs with and without co- 
expression of MbtH proteins. This lead to significantly improved expression 
behavior for all tested constructs. We could observe expression of all con-
structs and eliminate insoluble protein almost entirely, in favor of the highly 
soluble MBP-Hpg variant. The qualitative expression results were indepen-
dent of MbtH utilization, although, co-expression increased the total amount 
of soluble MBP-Hpg. The positive effect of MBP-tag introduction is best illus-
trated comparing Hpg11, 21, 22 and 23, which were previously not expressed 
at all (data not shown). Another notable observation is the high affinity bind-
ing of MbtH variant Tcp13. It did not only increase protein amount, but also 
co-eluted with all tested domains. To further elucidate the promiscuity and 
effect of the different MbtH variants, 4 A domain constructs and their 3 re-
spective MbtH variants were chosen for co-expression trials. The selection in-
cludes two domains and two MbtH homologs of the teicoplanin biosynthetic 
cluster, starter module A domain Tcp9 (AT) and elongation module A domain 
Hpg22 (A) plus the MbtH proteins Tcp13 and Tcp17, and the constructs Hpg25 
(A) and Hpg27 (ATE), comprising the same elongation A-domain and their re-
spective MbtH VEG8, derived from a metagenomic sample. Comparing the 
performance of the different MbtH variants, Tcp13 showed the overall best 

































































































































































































































































































































































































































































Table 2 — Pyrophosphate release rates of hpg modules, co-expressed with selected MbtH 
variants. 
Values are expressed as a function of (PPi) µM min-1 (Enzyme) µM-1. The color code is set at 
red = low (0)/ green = high (3). The high activity of Tcp9 is the most striking feature of this 
data set. N=2; error of mean overall = 0.056.
D-hpg L-hpg D-pg L-pg L-phe
0.1 mM 1 mM 0.1 mM 1 mM 1 mM 1 mM 1 mM
Tcp9
Tcp13 2.07 5.28 1.18 1.16 0.05 1.32 0.00
Tcp17 1.71 4.63 1.20 1.34 0.05 1.44 0.00
Veg8 3.72 8.44 1.23 1.40 0.07 2.32 0.00
Hpg22
Tcp13 0.08 0.66 0.80 1.03 0.00 0.17 0.00
Tcp17 0.11 0.63 0.95 1.04 0.04 0.23 0.00
Veg8 0.00 0.86 1.38 1.54 0.00 0.09 0.00
Hpg25
Tcp13 0.14 0.92 0.56 0.59 0.01 0.17 0.00
Tcp17 0.17 1.03 0.70 0.64 0.02 0.14 0.00
Veg8 0.18 1.39 0.61 0.61 0.02 0.20 0.00
Hpg27
Tcp13 0.12 0.72 0.54 0.57 0.01 0.15 0.00
Tcp17 0.11 0.62 0.48 0.52 0.01 0.12 0.00






























































































Figure 3 — Hpg22, 25, 27 and Tcp9 co-expression with the MbtH Tcp11, 13 and VEG8.
The constructs Hpg22, 25, 27 and Tcp9 were co-expressed with three MbtH variants. The 
protein input was adjusted according to culture OD. Differences can be observed between 


























































associated domains, VEG8 seems to surpass Tcp17 in terms of its beneficial 
effects on expression. Interestingly, Hpg25 expression increased equally by 
co-expression of VEG8, intrinsic to the domain, and Tcp13. The impact of the 
non-native MbtH is even more drastic for Hpg27, in combination with Tcp17, 
which exhibits the weakest effects for the other enzymes. Quantitation of the 
expression shows that despite affecting the levels of soluble protein, no alter-
ations in the 1:2 stoichiometry of A domain to MbtH was evident.
Substrate profiling of hpg domains
To confirm the previously predicted specificity towards hpg, the enzymes 
were subjected to a pyrophosphate exchange reaction to assess their sub-
strate dependent adenylation potential. Therefore, domains were overex-
pressed and purified using affinity chromatography targeting the C-terminal 
his tag. Isolated domains and modules were adjusted to a final concentra-
tion of 1 µM and screened for L- or D- hpg and L- or D-pg at 0.1 and 1 mM, 
respectively. Phenylalanine (1 mM) and substrate free reactions served as 
negative controls. An initial screen showed activity for 15 out of 16 A do-
mains towards L-hpg and/or D-hpg (Supplementary table 3). To compare the 
impact of domain setup and MbtH variants, four A domain constructs were 
selected for an in depth analysis. Tcp9 (AT) and Hpg22 (A), of the teicoplanin 
cluster, as well as Hpg25 (A) and 27 (ATE) of the VEG cluster, representing 
the same selection as previously stated for the in depth expression analysis 
(Figure 3). The enzymes were co-expressed with one of their intrinsic MbtH 
variants Tcp13, Tcp17 or VEG8 and subjected to in vitro analysis. Comparing 
the specificities of the selected domains, an overall higher adenylation veloc-
ity can be observed with reactions containing L-hpg and D-hpg. Furthermore, 
all enzymes show activity towards L-pg, however, only Tcp9 (AT) + VEG8 
shows significant activity towards D-pg. None of the reactions containing 
L-phenylalanine showed any product formation (Table 2). Moreover, there 
was no clear overall effect on the L- and D-hpg stereoselectivity. Though 
a slight D-hpg preference was observable with Hpg22, which is even more 
pronounced for Tcp9. A 5-fold increased velocity towards D-hpg was mea-
sured comparing to the 3 other constructs in the selection. Tcp9 showed 
overall higher velocities, in a range of 0.07 to 8.44 µM min-1 µM-1 for D-pg 
and D-hpg, respectively. The variance within Hpg22, Hpg25 and Hpg27 was 
generally lower. Rates of Hpg22 at 0.04 and 1.54 µM min-1 µM-1 for D-pg and 
D-hpg were observed, respectively. The latter activity represents the highest 





In addition to the substrate specificity, the performance of the differ-
ent MbtH homologs was evaluated. VEG8 appears to be the most promis-
cuous homologue, as it improves the catalytic properties of the A domains 
in the most significant manner. Tcp13 and 17 exhibit comparable properties, 
although at slightly lower levels. To assess the effects of omitting MbtH, 
Hpg20 and Hpg25 were compared with and without COM and Tcp13, respec-
tively (Figure 4). Even though, Hpg25 showed notable activity towards L-hpg, 
the velocity increased dramatically upon co-expression of VEG8. An even 















































Figure 4 — Effect of MbtH co-expression and co-purification on the adenylation activity 
of domains Hpg20 and Hpg25. 
A slight turnover of L-hpg by Hpg25 is detected without an MbtH, the activity increases 
dramatically upon the presence of its intrinsic MbtH variant VEG8. The impact on Hpg20 



























































activation was observed. However, upon COM addition, adenylation of the 
substrates L-hpg and to a lower degree D-hpg were measured.
Discussion 
Adenylation domains are essential core components of NRPS enzymes. Their 
ability to recruit a substrate with a high specificity makes them key elements 
in the synthesis of complex nonribosomal peptides. The diversity of dedi-
cated substrate recognition is tremendous, as over 500 substrates have been 
identified [42]. However, due to a significant degree of structural conser-
vation among A domains, specificity prediction software is well developed. 
Several programs allow for considerably accurate substrate predictions, in-
cluding the NRPSpredictor [47]. This allowed the selection of domains in this 
study, which have the potential to adenylate the predicted 4-hydroxyphenyl-
glycine substrate. Moreover, linker regions, domains and modules were accu-
rately pinpointed, leading to a set of fully functional constructs. 
In addition to protein domain prediction, corresponding adenylation helper 
proteins or MbtH homologs, were successfully identified, even from unan-
notated sources, as for VEG8 and TEG. Because of the high degree of con-
servation, 7 MbtH sequences were identified, selected and subjected to co- 
expression and purification studies. Even though the precise stoichiometry 
of A domains: MbtH is still poorly defined [16], we consistently observed a 
1:2 ratio, confirming other studies [16–17]. Furthermore, a typical co-elution 
pattern emerged. Every tested domain allowed for MbtH binding of native, as 
well as non-native MbtH variants. Due to the high degree of structural conser-
vation among NRPS modules and MbtH proteins, the question, if non- native 
MbtH do influence A domain behavior was addressed. It has been shown pre-
viously [48] that upon deletion or silencing of MbtH homologs, another ge-
nome encoded variant can compensate for the loss. This is in line with the 
behavior of the tested Tcp13, Tcp17 and VEG8 variants. All three homologs 
allowed for improved expression and significantly increased amino acid ac-
tivation rates, when tested in vitro with the domains Tcp9, Hpg22, 25 and 27. 
However, the degree of their influence seems to depend on the homolog used, 
and importantly, native copies did not always result in the strongest effects. 
Furthermore, also the domain setup of the A domain seems to play a key role 
as illustrated by the comparison of Hpg25 and Hpg27, which consist of A only 
and A + Te, respectively. Even though, this is not representative for all tested 
domains, it points at an overruling structural and conformational mechanism, 
















proteins. The differences in performance may be attributed to altered asso-
ciation properties. Focusing on the hypothetical interaction site as described 
by [19], two positions within the binding region of VEG8 compared to Tcp13 
and 17 are altered. Residues A28T and D34A represent the only changes in a 
stretch of 13 amino acids. Especially the change from aspartic acid to alanine 
at position 34 seems rather drastic. Taking into account, that the A domain in-
teraction sites are unaffected (Figure 2B), this mutation might play a key role 
in the observed differences of MbtH performance. However, only a thorough 
analysis of both complementing docking sites, paired with extensive muta-
tional studies, could lead to a conclusive answer. 
Finally, the narrow range substrate profiles of the selected enzymes were 
determined. Overall, every module, independent of domain setup or module 
placement, has significant activity towards L- and D- hpg, and in most cases 
also exhibits L-pg adenylation activity. However, only Hpg25 shows trace-
able activity without MbtH addition, underlining the essential role of MbtH 
proteins in the substrate activation process. Depending upon the MbtH ho-
molog used, an effect on activity, non-linear with co-expression performance, 
can be observed. This suggests that there is at least a dual role of MbtH 
proteins, i.e., chaperoning the expression/folding and promoting the activity.
Despite MbtH homologs, also module placement within the NRPS seems 
to influence the kinetic properties in vitro, best illustrated with the Initiation 
module Tcp9 (Table 2). The reason for this may be in the independence of ad-
jacent, upstream domains and modules, allowing for a higher degree of flex-
ibility, thus more rapid conformational changes of the Asub domain. It could 
further suggest, that due to the elevated adenylation rates, initiation mod-
ules could serve as gatekeepers for the NRPS. Product formation cycles may 
not be initiated without activation of the first module, which is also indicated 
by the kinetic intermediate step analysis of GrsA [39]. Foremost, in contrast 
to previous findings [49], we demonstrate the essential role of MbtH homo-
logues in the activation of hpg specifific adenlyation domains.
Conclusions and Perspectives
We have successfully demonstrated how NRPS modules, activating a 
non-proteinogenic compound, can be identified, overexpressed and char-
acterized. Through bioinformatics tools, alongside a non-radiolabel, multi-
well, pyrophosphate exchange assay, a medium to high throughput experi-
mental setup was established. Due to a high degree of conservation among 


























































setup allows for the identification and characterization of novel domains, ac-
tivating any of the over 500 known substrates. With respect to the rapid im-
provements in engineering techniques [50] for multi-modular enzymes, this 
method provides a fast and straight forward way of increasing the target pool 
of domains. By using this pool, this could give rise to novel NRPS systems, 
which are able to efficiently synthetize customized compounds with new 
application spectra and contribute to ever growing demand of novel bioac-
tive compounds, including the thriving search for new, alternative antibiotics.
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Supplementary data Table 1 — First selection of targets. 
Stachelhaus code was determined in NRPSpredictor. Targets for final selection are highlighted in grey.
organism enzyme module
Actinoplanes ATCC 33076 NRPS 1
Actinoplanes ATCC 33076 NRPS 4
Actinoplanes ATCC 33076 NRPS 5
Actinoplanes ATCC 33076 NRPS 2
Actinoplanes ATCC 33076 NRPS 4
Actinoplanes ATCC 33076 NRPS 8
Chlorobium phaeobacteroides DSM 266 Amino acid adenylation domain 1
Herpetosiphon aurantiacus ATCC 23779 Amino acid adenylation domain 1
Herpetosiphon aurantiacus ATCC 23779 Amino acid adenylation domain 2
Streptomyces griseus subsp. Griseus JCM 4626 NRPS 1
Adineta vaga NRPS-like protein 3
Uncultured soil bacterium NRPS 1
Uncultured soil bacterium NRPS 1
Uncultured soil bacterium NRPS 1
Uncultured soil bacterium NRPS 2
Uncultured soil bacterium NRPS 1
Uncultured soil bacterium NRPS 1
Uncultured soil bacterium NRPS 2
Bacillus mycoides Rock 1–4 ATP-dependent leucine adenylase 1
Dickeya dadantii (strain Ech703) Amino acid adenylation domain 1
Chitinophaga pinensis (strain ATCC 43595) AMP-dependent synthetase and ligase 1
Streptomyces sp. ACT-1 Amino acid adenylation domain 1
Streptomyces roseosporus NRRL 15998 NRPS 2
Streptomyces lividans TK24 NRPS 5
Segniliparus rotundus (strain DSM 44985) Amino acid adenylation domain 1
Amycolatopsis orientalis NRPS 1
Amycolatopsis orientalis NRPS 2
Streptomyces fungicidicus NRPS 2
Streptomyces fungicidicus NRPS 4
Streptomyces fungicidicus NRPS 8
Streptomyces fungicidicus NRPS 1
Streptomyces fungicidicus NRPS 4
Streptomyces fungicidicus NRPS 5
Shewanella denitrificans (strain DSM 15013) Amino acid adenylation domain 1
Frankia sp. (strain CcI3) Amino acid adenylation domain 3
Nocardia farcinica NRPS 1
Actinoplanes teichomyceticus NRPS 1
Actinoplanes teichomyceticus NRPS 2
Actinoplanes teichomyceticus NRPS 1
Actinoplanes teichomyceticus NRPS 1
Actinoplanes teichomyceticus NRPS 2
Actinoplanes teichomyceticus NRPS 1
Nonomuraea sp. ATCC 39727 NRPS 1
Nonomuraea sp. ATCC 39727 NRPS 1
Nonomuraea sp. ATCC 39727 NRPS 2
Streptomyces toyocaensis NRPS 1
Streptomyces toyocaensis NRPS 1
Streptomyces toyocaensis NRPS 2
Amycolatopsis mediteranei DSM 5908 NRPS 1
Amycolatopsis mediteranei DSM 5908 NRPS 2
Streptomyces lavendulae NRPS 1
Streptomyces lavendulae NRPS 1
Streptomyces lavendulae NRPS 2
Streptomyces lavendulae NRPS 1
Streptomyces lavendulae NRPS 1
Streptomyces coelicolor NRPS 6
Streptomyces coelicolor NRPS 1





































































lcl|UniRef100_B7T1C1_m1 DIFHLGLLCK D-hydroxyphenylglycine Hpg25/27
lcl|UniRef100_B7T1C1_m2 DAVHLGLLCK D-hydroxyphenylglycine
lcl|UniRef100_B7T1D0_m1 DAFHLGLLCK L/D-hydroxyphenylglycine























lcl|UniRef100_Q70AZ7_m1 DIFHLGLLCK D-hydroxyphenylglycine Hpg22
lcl|UniRef100_Q70AZ7_m2 DALHLGLLCK D-hydroxyphenylglycine
lcl|UniRef100_Q70AZ9_m1 DAFHLGLLCK D-hydroxyphenylglycine Tcp9
lcl|UniRef100_Q7WZ66_m1 DAFHLGLLCK D-hydroxyphenylglycine Hpg3/4
lcl|UniRef100_Q7WZ74_m1 DIFHLGLLCK D-hydroxyphenylglycine
lcl|UniRef100_Q7WZ74_m2 DALHLGLLCK D-hydroxyphenylglycine
lcl|UniRef100_Q8KLL3_m1 DAFHLGLLCK D-hydroxyphenylglycine Hpg1
lcl|UniRef100_Q8KLL5_m1 DIFHLGLLCK D-hydroxyphenylglycine
lcl|UniRef100_Q8KLL5_m2 DAFHLGLLCK D-hydroxyphenylglycine Hpg21
lcl|UniRef100_Q939Z0_m1 DIFHLGLLCK D-hydroxyphenylglycine Hpg11




lcl|UniRef100_Q93N88_m1 DIFHLGLLCK D-hydroxyphenylglycine Hpg20/26
lcl|UniRef100_Q93N89_m1 DIFHLGLLCK D-hydroxyphenylglycine














Supplementary data Table 2 — Overview of all over expression experiments. 
S is soluble, I insoluble expression of the construct; N/A not applicable; MbtH indicates the 
MbtH variants which were used for co-expression trials. Underlined MbtH enabled activity 
with the dedicated construct.
Construct pSCI 242/243   pMAL-c5x   MbtH 
  S I   S I    
Tcp9 n/a n/a   Yes Yes  Tcp13; Tcp17; Veg8
Hpg1 n/a n/a   Yes Yes   Tcp13; Veg8
Hpg3 n/a n/a   Yes Yes   Tcp13; Veg8
Hpg11 No No   Yes Yes   Tcp13; Bps
Hpg12 No No   Yes Yes   Tcp13
Hpg13 Yes Yes   Yes Yes   Tcp13
Hpg14 Yes Yes   Yes Yes   Tcp13
Hpg15 Yes Yes   N/A N/A   N/A
Hpg16 Yes Yes   N/A N/A   N/A
Hpg17 Yes Yes   N/A N/A   N/A
Hpg18 No Yes   N/A N/A   N/A
Hpg19 Yes Yes   Yes Yes   Tcp13; CDAI
Hpg20 Yes Yes   Yes Yes   Tcp13; Com
Hpg21 No No   Yes Yes   Tcp13
Hpg22 No No   Yes Yes   Tcp13; Tcp17; Veg8
Hpg23 No No   Yes Yes   Tcp13; Teg
Hpg24 No No   Yes Yes   Tcp13
Hpg25 Yes Yes   Yes Yes   Tcp13; Tcp17; Veg8
Hpg26 Yes Yes   Yes Yes Tcp13; Com
Hpg27 Yes Yes   Yes Yes   Tcp13; Tcp17; Veg8
Supplementary table 3 — Overview of the adenylation activity determinations for the 
different amino acid substrates and the different combinations of adenylation domain 
constructs with co-purified MbtH-like proteins. 
MbtHs enabling any adenylation activity are underlined. N/A not applicable.
Construct L-hpg D-hpg   L-pg D-pg   L-phe   MbtH 
Tcp9 Yes Yes   Yes No   No   Tcp13; Tcp17; Veg8
Hpg1 Yes Yes   Yes No   No   Tcp13; Veg8
Hpg3 Yes Yes   Yes No   No   Tcp13; Veg8
Hpg11 Yes No   No No   No   Tcp13; Bps
Hpg12 N/A N/A   N/A N/A   N/A   N/A
Hpg13 Yes No   No No   No   Tcp13
Hpg14 Yes No   No No   No   Tcp13
Hpg15 N/A N/A   N/A N/A   N/A   N/A
Hpg16 N/A N/A   N/A N/A   N/A   N/A
Hpg17 N/A N/A   N/A N/A   N/A   N/A
Hpg18 N/A N/A   N/A N/A   N/A   N/A
Hpg19 Yes No   No No   No   Tcp13; CDAI
Hpg20 Yes No   No No   No   Tcp13; Com
Hpg21 Yes Yes   No No   No   Tcp13
Hpg22 Yes Yes   Yes No   No   Tcp13; Tcp17; Veg8
Hpg23 Yes No   No No   No   Tcp13; Teg
Hpg24 Yes Yes   Yes No   No   Tcp13
Hpg25 Yes Yes   Yes No   No   Tcp13; Tcp17; Veg8
Hpg26 Yes No   No No   No   Tcp13; Com


























































Supplementary figure 1 — Alignment of all adenylation domains in this study. 
ClustalX was used to align the sequences of all tested adenylation domains.

